Physician profile
Luann Moraski
NPI 1689625436
$1,397.82
in general payments reported to CMS, 2019-2025
15 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.50 · 2020: $11.19 · 2021: $96.11 · 2022: $226 · 2023: $214 · 2024: $615 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $973.33 | 2021-2025 | |
| Tris Pharma INC | $66.16 | 2024-2025 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $58.06 | 2024-2025 | Jornay Pm, Xtampza |
| Almatica Pharma LLC | $39.21 | 2022-2025 | Loreev Xr |
| Novo Nordisk INC | $35.23 | 2024-2025 | Rybelsus, Ozempic |
| Supernus Pharmaceuticals, INC. | $34.75 | 2024 | Qelbree |
| Axsome Therapeutics, INC. | $34.60 | 2024 | Auvelity |
| Pfizer INC. | $33.29 | 2024 | |
| Sanofi-Aventis U.S. LLC | $24.73 | 2020-2021 | |
| Exact Sciences Corporation | $21.08 | 2024 | Cologuard Collection Kit |
| Abbott Laboratories | $20.31 | 2024 | Freestyle Libre 3 |
| Vanda Pharmaceuticals INC. | $16.63 | 2025 | Fanapt |
| Arbor Pharmaceuticals, INC. | $15.38 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.56 | 2022 | |
| Amgen INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luann Moraski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.